Ho Chi Sing - 30 Sep 2025 SCHEDULE 13D/A Report for CASI Pharmaceuticals, Inc. Ordinary Shares, par value US$0.0001 per share (CASI)

Filing Manager
Ho Chi Sing
Reporting Manager
Zhou Quan
Security
CASI Pharmaceuticals, Inc. Ordinary Shares, par value US$0.0001 per share
Symbol
CASI
Shares outstanding
20,679,958 shares
Disclosed Ownership
992,638 shares
Ownership
4.8%
Form type
SCHEDULE 13D/A
Filing time
20 Jan 2026, 09:33:06 UTC
Date of event
30 Sep 2025
Previous filing
03 Feb 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
IDG-Accel China Growth Fund III L.P. 4.5% 915,850 855,222 60,628 /s/ Chi Sing Ho on behalf of IDG-Accel China Growth Fund GP III Associates Ltd., ultimate General Partner of IDG-Accel China Growth Fund III L.P. Chi Sing Ho / Authorized Signatory 0001508829
IDG-Accel China III Investors L.P. 4.5% 915,850 60,628 855,222 /s/ Chi Sing Ho on behalf of IDG-Accel China Growth Fund GP III Associates Ltd., General Partner of IDG-Accel China III Investors L.P. Chi Sing Ho / Authorized Signatory 0001550193
IDG-Accel China Growth Fund III Associates L.P. 4.5% 915,850 855,222 60,628 /s/ Chi Sing Ho on behalf of IDG-Accel China Growth Fund GP III Associates Ltd., General Partner of IDG-Accel China Growth Fund III Associates L.P. Chi Sing Ho / Authorized Signatory 0001550192
IDG-Accel China Growth Fund GP III Associates Ltd. 4.5% 915,850 915,850 0 /s/ Chi Sing Ho Chi Sing Ho / Authorized Signatory 0001564281
Ho Chi Sing 4.5% 915,850 0 915,850 /s/ Ho Chi Sing Ho Chi Sing 0001545806
Zhou Quan 4.8% 992,638 76,788 915,850 /s/ Quan Zhou Quan Zhou 0001491503